90 related articles for article (PubMed ID: 19340835)
1. Design and synthesis of a gossypol derivative with improved antitumor activities.
Zhan Y; Jia G; Wu D; Xu Y; Xu L
Arch Pharm (Weinheim); 2009 Apr; 342(4):223-9. PubMed ID: 19340835
[TBL] [Abstract][Full Text] [Related]
2. Comparison of XTT and Alamar blue assays in the assessment of the viability of various human cancer cell lines by AT-101 (-/- gossypol).
Uzunoglu S; Karaca B; Atmaca H; Kisim A; Sezgin C; Karabulut B; Uslu R
Toxicol Mech Methods; 2010 Oct; 20(8):482-6. PubMed ID: 20843265
[TBL] [Abstract][Full Text] [Related]
3. Apogossypolone, derivative of gossypol, mobilizes endogenous copper in human peripheral lymphocytes leading to oxidative DNA breakage.
Zubair H; Khan HY; Ullah MF; Ahmad A; Wu D; Hadi SM
Eur J Pharm Sci; 2012 Aug; 47(1):280-6. PubMed ID: 22554693
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and biological evaluation of Apogossypolone derivatives as pan-active inhibitors of antiapoptotic B-cell lymphoma/leukemia-2 (Bcl-2) family proteins.
Wei J; Kitada S; Stebbins JL; Placzek W; Zhai D; Wu B; Rega MF; Zhang Z; Cellitti J; Yang L; Dahl R; Reed JC; Pellecchia M
J Med Chem; 2010 Nov; 53(22):8000-11. PubMed ID: 21033669
[TBL] [Abstract][Full Text] [Related]
5. Mobilization of Intracellular Copper by Gossypol and Apogossypolone Leads to Reactive Oxygen Species-Mediated Cell Death: Putative Anticancer Mechanism.
Zubair H; Azim S; Khan HY; Ullah MF; Wu D; Singh AP; Hadi SM; Ahmad A
Int J Mol Sci; 2016 Jun; 17(5):. PubMed ID: 27331811
[TBL] [Abstract][Full Text] [Related]
6. Chiral gossypol derivatives: evaluation of their anticancer activity and molecular modeling.
Zhang L; Jiang H; Cao X; Zhao H; Wang F; Cui Y; Jiang B
Eur J Med Chem; 2009 Oct; 44(10):3961-72. PubMed ID: 19447525
[TBL] [Abstract][Full Text] [Related]
7. Developing gossypol derivatives with enhanced antitumor activity.
Liang XS; Rogers AJ; Webber CL; Ormsby TJ; Tiritan ME; Matlin SA; Benz CC
Invest New Drugs; 1995; 13(3):181-6. PubMed ID: 8729944
[TBL] [Abstract][Full Text] [Related]
8. ApoG2 inhibits the antiapoptotic protein, Mcl‑1, and induces mitochondria‑dependent apoptosis in human colorectal cancer cells.
Li T; Yuan G; Zhang L; Ye L; Li S; Fan Y; Sun J
Mol Med Rep; 2015 Nov; 12(5):6976-84. PubMed ID: 26352605
[TBL] [Abstract][Full Text] [Related]
9. ApoG2 as the most potent gossypol derivatives inhibits cell growth and induces apoptosis on gastric cancer cells.
Xin J; Zhan YH; Xia LM; Zhu HW; Nie YZ; Liang JM; Tian J
Biomed Pharmacother; 2013 Feb; 67(1):88-95. PubMed ID: 23201009
[TBL] [Abstract][Full Text] [Related]
10. A novel water-soluble gossypol derivative increases chemotherapeutic sensitivity and promotes growth inhibition in colon cancer.
Yan F; Cao XX; Jiang HX; Zhao XL; Wang JY; Lin YH; Liu QL; Zhang C; Jiang B; Guo F
J Med Chem; 2010 Aug; 53(15):5502-10. PubMed ID: 20684596
[TBL] [Abstract][Full Text] [Related]
11. Profiling of angiogenic cytokines produced by hormone- and drug-refractory prostate cancer cell lines, PC-3 and DU-145 before and after treatment with gossypol.
Karaca B; Kucukzeybek Y; Gorumlu G; Erten C; Gul MK; Cengiz E; Atmaca H; Uzunoglu S; Sanli UA; Karabulut B; Uslu R
Eur Cytokine Netw; 2008 Dec; 19(4):176-84. PubMed ID: 19103523
[TBL] [Abstract][Full Text] [Related]
12. Structure-based design of potent small-molecule inhibitors of anti-apoptotic Bcl-2 proteins.
Wang G; Nikolovska-Coleska Z; Yang CY; Wang R; Tang G; Guo J; Shangary S; Qiu S; Gao W; Yang D; Meagher J; Stuckey J; Krajewski K; Jiang S; Roller PP; Abaan HO; Tomita Y; Wang S
J Med Chem; 2006 Oct; 49(21):6139-42. PubMed ID: 17034116
[TBL] [Abstract][Full Text] [Related]
13. Apogossypolone, a novel inhibitor of antiapoptotic Bcl-2 family proteins, induces autophagy of PC-3 and LNCaP prostate cancer cells in vitro.
Zhang XQ; Huang XF; Hu XB; Zhan YH; An QX; Yang SM; Xia AJ; Yi J; Chen R; Mu SJ; Wu DC
Asian J Androl; 2010 Sep; 12(5):697-708. PubMed ID: 20657602
[TBL] [Abstract][Full Text] [Related]
14. Antiproliferative activity of gossypol and gossypolone on human breast cancer cells.
Gilbert NE; O'Reilly JE; Chang CJ; Lin YC; Brueggemeier RW
Life Sci; 1995; 57(1):61-7. PubMed ID: 7596222
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and cytotoxicity of gossypol related compounds.
Dao VT; Gaspard C; Mayer M; Werner GH; Nguyen SN; Michelot RJ
Eur J Med Chem; 2000 Sep; 35(9):805-13. PubMed ID: 11006482
[TBL] [Abstract][Full Text] [Related]
16. In vitro effects of the BH3 mimetic, (-)-gossypol, on head and neck squamous cell carcinoma cells.
Oliver CL; Bauer JA; Wolter KG; Ubell ML; Narayan A; O'Connell KM; Fisher SG; Wang S; Wu X; Ji M; Carey TE; Bradford CR
Clin Cancer Res; 2004 Nov; 10(22):7757-63. PubMed ID: 15570010
[TBL] [Abstract][Full Text] [Related]
17. Lactic dehydrogenase isozymes, 31P magnetic resonance spectroscopy, and in vitro antimitochondrial tumor toxicity with gossypol and rhodamine-123.
Benz C; Hollander C; Keniry M; James TL; Mitchell M
J Clin Invest; 1987 Feb; 79(2):517-23. PubMed ID: 3805280
[TBL] [Abstract][Full Text] [Related]
18. Inhibitory effects of gossypol, gossypolone, and apogossypolone on a collection of economically important filamentous fungi.
Mellon JE; Zelaya CA; Dowd MK; Beltz SB; Klich MA
J Agric Food Chem; 2012 Mar; 60(10):2740-5. PubMed ID: 22324794
[TBL] [Abstract][Full Text] [Related]
19. Synthesis of gossypol atropisomers and derivatives and evaluation of their anti-proliferative and anti-oxidant activity.
Dodou K; Anderson RJ; Lough WJ; Small DA; Shelley MD; Groundwater PW
Bioorg Med Chem; 2005 Jul; 13(13):4228-37. PubMed ID: 15878283
[TBL] [Abstract][Full Text] [Related]
20. Inhibitory effects of gossypol-related compounds on growth of Aspergillus flavus.
Mellon JE; Zelaya CA; Dowd MK
Lett Appl Microbiol; 2011 Apr; 52(4):406-12. PubMed ID: 21291481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
